BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


SOLVO Biotechnology is introducing new P-gp PREDIVEZ Vesicular Transport Kit

May 9th 2008: I am pleased to inform you, that SOLVO is introducing the new P-gp PREDIVEZTM kit that is a breakthrough in P-gp interaction assessment. The assay measures drug-transporter interaction in membrane vesicles expressing human P-gp or rat Mdr1b.  The revolutionary PREDIVEZTM kit allows a faster and more cost effective investigation of the drug candidate and P-gp interaction than lower throughput cellular assays, such as Caco-2, MDCK-MDR1 or LLC-PK MDR1 cell-based systems.  

SOLVO’s new vesicular transport assay operates with a low permeability, cationic, radio-labeled substrate (N-methyl-quinidine) that is transported by both MDR1 and ratMdr1b transporters. The human P-gp PREDIVEZTM kit works with human membrane vesicles while the rat Mdr1b PREDIVEZTM kit contains insect membrane preparation expressing the rodent ABC transporter. 

Please find detailed information and reference data of P-gp and rat Mdr1b PREDIVEZTM Kits here: P-gp PREDIVEZTM kit

Both kits are available in three sizes: 3, 6 and 9 compounds. Each kit contains sufficient amount of reagents and membrane preparation for testing 3 compounds per 96-well plate. Negative control membranes and positive control reference materials are also included. Each kit is accompanied by a CD that includes the assay protocol, Excel spreadsheet with data processing template, MSDS and reference curves with known interactors.

The price of the kit includes the cost of the radio labeled reporter substrate, which is shipped separately. The labeled reporter compound comes in a single size package, sufficient for testing 9 compounds. Kits are also available without the labeled reporter compound.

In case you are planning to try SOLVO’s new P-gp PredivezTM kit – MDR1 or rat Mdr1b -, I would encourage you to do it now. As an introductory offer SOLVO is going to credit 10 % of the total cost ordered against any PREDEASYTM ATPase or PREDIVEZTM fluorescent VT kits purchased until August 31, 2008.

Contact:
Orsolya Hamar, MBA
Marketing Manager, Business Development
SOLVO Biotechnology
Central Hungarian Innovations Center
Gyár u. 2, Budaörs
H-2040 Hungary
Tel: +36-23-503-940
Fax: +36-23-503-941
Cell: +36-30-239-4598
www.solvo.com
 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.